ArticleScientific reports2025
Nanopore sequencing reveals the genomic diversity of the variants of concern of SARS-CoV-2 during 2021 disease outbreak in Pakistan.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Process and analytical strategies for the safe production of mRNA vaccines and therapeutics.Molecular biology reports · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The global spread of SARS-CoV-2 was significantly impacted by the emergence of Variants of Concern (VOC), with Pakistan experiencing similar trends to other countries. To gain a comprehensive understanding of the genomic epidemiology of SARS-CoV-2 strains circulating during Pakistan's third and fourth pandemic waves, we conducted the largest single sequencing effort in the country to date. Using the GridION platform (Oxford Nanopore Technologies), we performed whole genome sequencing on 1052 confirmed COVID-19 patient samples collected from multiple cities across Pakistan between March and October 2021. Our analysis revealed a clear temporal shift in variant dominance. The Alpha variant (B.1.1.7 lineage) predominated in the first half of 2021, while the Delta variant (B.1.617.2) became most prevalent in the latter half. This transition reflects global trends and provides crucial insights into the timing and dynamics of this shift within Pakistan. Mutational analysis revealed that the most frequent nucleotide mutations in Pakistani SARS-CoV-2 samples were A23403G (associated with the D614G mutation in the spike protein), C3037T, C14408T, and C241T, potentially contributing to increased disease transmission and evasion of host immune responses. The rapid evolution and spread of these circulating variants highlight the possibility of novel variants emerging with enhanced mutational fitness. The AY.108 lineage, which has been reported at relatively low frequencies globally including in Europe and North America, with Pakistan accounting for approximately 34% of global cases, suggesting potential regional evolution or specific introduction events. Our findings underscore the dynamic nature of SARS-CoV-2 and emphasize the critical importance of ongoing, large-scale genomic surveillance in Pakistan. This study demonstrates the feasibility and utility of using nanopore sequencing for comprehensive viral monitoring in Pakistan's public health context. While we utilized the higher-throughput GridION platform for centralized processing, the Oxford Nanopore technology still provided distinct advantages through its simplified library preparation protocol, flexible run capacities, and reduced computational requirements for base-calling compared to traditional high-throughput sequencers. These benefits enabled efficient processing of our large sample batches collected from distributed sites across the country, demonstrating a scalable approach for genomic surveillance that balances throughput needs with resource availability. This could inform future public health strategies, including vaccine updates and targeted interventions. Continued monitoring and adaptive strategies are essential to keep pace with the evolving viral ecology and to enhance preparedness for future outbreaks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.